These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 8226438

  • 1. A clarithromycin sensitivity survey in the United Kingdom using Stokes' method.
    Humphreys JE, Smith EG, Coles SJ.
    J Antimicrob Chemother; 1993 Aug; 32(2):341-2. PubMed ID: 8226438
    [No Abstract] [Full Text] [Related]

  • 2. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus.
    Nord CE, Lindmark A, Persson I.
    J Chemother; 1989 Jul; 1(4 Suppl):203-4. PubMed ID: 16312369
    [No Abstract] [Full Text] [Related]

  • 3. Comparative in vitro activity of A-56268 against respiratory tract pathogens.
    Jansson L, Kalin M.
    Eur J Clin Microbiol; 1987 Aug; 6(4):494-6. PubMed ID: 2959474
    [No Abstract] [Full Text] [Related]

  • 4. Comparative antimicrobial activity of the new macrolide flurithromycin against respiratory pathogens.
    Nord CE, Lindmark A, Persson I.
    Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):71-3. PubMed ID: 3132384
    [Abstract] [Full Text] [Related]

  • 5. [Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000].
    Melo-Cristino J, Fernandes ML, Serrano N, Grupo de Estudo Português de Bactérias Patogénicas Respiratórias.
    Acta Med Port; 2001 Feb; 14(5-6):459-68. PubMed ID: 11878155
    [Abstract] [Full Text] [Related]

  • 6. [Current in vitro sensitivity of the most frequent bacterial respiratory pathogens: clinical implications].
    Oteo J, Alós JI, Gómez-Garcés JL.
    Med Clin (Barc); 2001 Apr 21; 116(14):541-9. PubMed ID: 11412622
    [No Abstract] [Full Text] [Related]

  • 7. [In vitro activity of trovafloxacin in 238 respiratory pathogens].
    Alarcón T, Domingo D, Prieto N, Sánchez S, López-Brea M.
    Rev Esp Quimioter; 1998 Mar 21; 11(1):47-51. PubMed ID: 9795289
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The Viriato Study: update of antimicrobial susceptibility data of bacterial pathogens from community-acquired respiratory tract infections in Portugal in 2003 and 2004.
    Melo-Cristino J, Santos L, Ramirez M, Grupo de Estudo Português de Bactérias Patogénicas Respiratórias.
    Rev Port Pneumol; 2006 Mar 21; 12(1):9-30. PubMed ID: 16572254
    [Abstract] [Full Text] [Related]

  • 10. [In vitro activity of moxifloxacin against respiratory pathogens in Latin America].
    López H, Sader H, Amábile C, Pedreira W, Muñoz Bellido JL, García Rodríguez JA, Grupo MSP-LA.
    Rev Esp Quimioter; 2002 Dec 21; 15(4):325-34. PubMed ID: 12587037
    [Abstract] [Full Text] [Related]

  • 11. Selection of resistance of telithromycin against Haemophilus influenzae, Moraxella catarrhalis and streptococci in comparison with macrolides.
    Drago L, De Vecchi E, Nicola L, Colombo A, Gismondo MR.
    J Antimicrob Chemother; 2004 Aug 21; 54(2):542-5. PubMed ID: 15215227
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antimicrobial resistance of Streptococcus pneumoniae, Haemophilius influenzae and Moraxella catarrhalis isolated in Hawaii.
    Zheng X, Davis E, Singh S, Watase R, Hirata K, Reppun T.
    Int J Antimicrob Agents; 2000 Aug 21; 15(3):231-3. PubMed ID: 10926447
    [No Abstract] [Full Text] [Related]

  • 14. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from class B hospitals in China during 2013 and 2014].
    Sun H, Chen L, Chen X, Jia X, Li N, Liu W, Tong H, Xiang R, Zhang F, Zhao H, Zhang J, Xu Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jan 21; 39(1):30-7. PubMed ID: 26792053
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.